Wednesday, Jun 25, 2025 · SEC filings

What the smart money revealed on Jun 25

Real insider buys18insiders · $8.88M
Real insider sales32insiders · $55.4M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

287 insider filings came in. We hid 48 planned (10b5-1) sellers and 175 people whose filings were routine, like grants and tax withholding.

trending_up

Vera Therapeutics (VERA) Director Patrick Enright bought $5.28M

250,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 5 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 5 beat Traded Jun 23–24
$5.28M
trending_up

Global Medical REIT (GMRE) CEO and President Mark Decker Jr. bought $1.04M

160,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jun 24–25
$1.04M
trending_up

Prospect Capital (PSEC) CEO John Barry bought $1.01M

319,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 0 of 6 beat Traded Jun 23
$1.01M
trending_up

SafeSpace Global (SSGC) Pres and Chief Strat Officer Dustin Hillis bought $636K

Open-market buys of more than one share class. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 24–Jun 23
$636K
trending_down

Broadcom (AVGO) Chief Legal and Corp Affairs Ofc Mark Brazeal sold $12.7M

Not marked as a planned 10b5-1 sale. Sold 11% of the shares they held directly. Still holds 415,956 shares.

Real sale Form 4 Traded Jun 23
$12.7M
trending_down

Broadcom (AVGO) President and CEO Hock Tan sold $10.5M

Not marked as a planned 10b5-1 sale. Sold 4% of the shares they held directly. Still holds 974,152 shares.

Real sale Form 4 Traded Jun 24
$10.5M
trending_down

BeOne Medicines (ONC) CEO John Oyler sold $830K

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jun 23
$830K
Show 14 more real buys
Show 29 more real sales
CRWD CrowdStrike · President and CEO George Kurtz · Traded Jun 23
$8.37M
CRWD CrowdStrike · President Michael Sentonas · Traded Jun 23
$5.43M
CRWD CrowdStrike · CFO Burt Podbere · Traded Jun 23
$5.03M
KFY Korn Ferry · EVP Robert Rozek · Traded Jun 24
$2.91M
OKLO Oklo · Director Michael Klein · Traded Jun 23
$2.74M
SRM SRM Entertainment · VP of Production Development Deborah McDaniel-Hand · Traded Jun 23
$941K
UTHR United Therapeutics · Director Richard Giltner · Traded Jun 24
$879K
STRL Sterling Infrastructure · General Counsel Mark Wolf · Traded Jun 24
$791K
MAR Marriott International · President Rajeev Menon · Traded Jun 24
$671K
SLDE Slide Insurance · Director Beth Bruce · Traded Jun 23
$491K
GWRE Guidewire Software · Director Michael Keller · Traded Jun 24–25
$477K
AISP Airship AI · President Paul Allen · Traded Jun 23
$358K
ONC BeOne Medicines · President and COO Xiaobin Wu · Traded Jun 23
$354K
ONC BeOne Medicines · Global Head of R&D Lai Wang · Traded Jun 23
$267K
ESP Espey MFG & Electronics · President and CEO David Oneil · Traded Jun 23–24
$240K
SYBT Stock Yards Bancorp · Executive Vice President William Dishman · Traded Jun 24
$219K
ESTC Elastic N.V. · Chief Revenue Officer Mark Dodds · Traded Jun 24
$209K
UTHR United Therapeutics · Director Nilda Mesa · Traded Jun 24
$187K
SLDE Slide Insurance · Director Stephen Rohde · Traded Jun 23
$175K
TRAK ReposiTrak · CEO Randall Fields · Traded Jun 23–25
$147K
AVNW Aviat Networks · VP Legal Affairs Erin Boase · Traded Jun 24
$110K
REPX Riley Exploration Permian · Director Brent Arriaga · Traded Jun 23
$110K
AMAT Applied Materials · Corp. Controller and CAO Adam Sanders · Traded Jun 24
$100K
TSQ Townsquare Media · COO Erik Hellum · Traded Jun 23
$70.9K
IPAR Interparfums · Director Gilbert Harrison · Traded Jun 23
$53.6K
SFST Southern First Bancshares · Director Leighton Cubbage · Traded Jun 23
$38.7K
GMGI Golden Matrix Group · Director Thomas McChesney · Traded Jun 23–24
$17.4K
OKUR OnKure Therapeutics · CFO Jason Leverone · Traded Jun 23
$721
OKUR OnKure Therapeutics · President and CEO Nicholas Saccomano · Traded Jun 23
$209

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist